New Delhi : In a decision that will cheer the domestic pharma industry, Indian firms including Dr Reddy’s, Lupin and Torrent have received nod from the US health regulator to market the first generic version of Aciphex, used to treat gastroesophageal reflux disease (GERD).

First generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease (GERD) in adults and adolescents (ages 12 and up) have been approved, US Food and Drug Administration said.
Dr Reddy’s Laboratories Ltd, Lupin Pharmaceuticals Inc, Kremers Urban Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd have received FDA approval to market generic rabeprazole, it added.
“Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigid standards of quality as the brand-name drug,” Acting director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research Kathleen Uhl said.

(For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal